• Professional Development
  • Medicine & Nursing
  • Arts & Crafts
  • Health & Wellbeing
  • Personal Development

455 Educators providing Courses delivered On Demand

Pcsk9 Education And Research Forum

pcsk9 education and research forum

Alcester

Reducing low density lipoprotein (LDL) cholesterol is the priority in managing patients with severe dyslipidaemia (cholesterol abnormality) and at high risk of cardiovascular (CV) death and disability. Yet even when treated with potent statins, many patients fail to achieve LDL-cholesterol targets and therefore their risk of accelerated atherosclerosis and CV death remains high. This problem is particularly critical in patients with familial hypercholesterolaemia (FH) (the most commonly occurring genetic condition in the world). People with FH typically have very high LDL cholesterol levels on treatment, and consequently, are at very high risk of premature and sudden CV death, myocardial infarction and stroke. Additionally, some patients are unable to tolerate statins – particularly at higher doses – and, therefore, do not achieve LDL-cholesterol goals. What is the importance of PCSK9? Discovered in 2003,1 PCSK9 is a protein made by the liver which increases the removal of LDL receptors from the surface of liver cells. These LDL receptors are critically important in removal of serum LDL-cholesterol from the circulation. People with so-called ‘gain of function’ PCSK9 mutations over-express PCSK9, and therefore have very high plasma levels of LDL cholesterol and are at very risk of atherosclerosis and CV mortality and morbidity.2 In contrast, people with so-called ‘loss of function’ PCSK9 mutations, have very LDL cholesterol levels and reduced risk for heart disease.3 What is PCSK9 inhibition? Different approaches to lowering PCSK9 are now licensed. These include fully human monoclonal antibodies (alirocumab, evolocumab) and a small-interfering RNA therapy (inclisiran). Trials show that these PCSK9 inhibitors reduce LDL cholesterol levels by about 50-60 percent - a significantly greater effect than that achieved with currently available therapies – either when given alone or in combination. These LDL cholesterol lowering effects have been consistently across a broad group of patients, including those with familial hypercholesterolaemia in clinical trials.4 Which clinical settings will benefit from the availability of PCSK9 inhibitors? These treatments offer the potential to reduce cardiovascular risk in patients whose clinical needs cannot be satisfied by current therapy. These include: Patients with familial hypercholesterolaemia – an inherited disorder of lipid metabolism with a very high risk of early CV death or morbidity, if not diagnosed or treated early Patients who cannot tolerate statins, who therefore remain at high risk of CV events such as heart attacks and strokes Patients with established heart disease who have not achieved LDL-cholesterol goals despite current therapies

Vp ESS Training

vp ess training

Wellingborough

With over 25 years of experience, ESS stands at the forefront of safety training, delivering expert instruction to thousands of delegates each year across a network of specialised training centres. Our commitment to safety excellence is reflected in the qualifications of our trainers, who uphold the highest industry standards and ensure that every delegate receives exceptional purposeful training.  Each of our training centres are approved by City & Guilds and RoSPA (The Royal Society for the Prevention of Accidents), guaranteeing that our services meet the highest professional benchmarks. All ESS Training centres are both City & Guilds and RoSPA approved. w: https://www.vp-ess.com/training/ t: 0800 000 346 e: esstrainingsales@vpplc.com ESS Training work alongside key qualification bodies such as RoSPA, City & Guilds, Qualsafe, ECITB, EUSR and many more to provide a range of accredited courses ranging from Confined Space Training and Manual Handling to Working at Heights, First Aid, Utility Detection, New Roads and Streetworks Training as well as virtual and e-learning modules.  We can provide tailored training solutions to satisfy your requirements for both theoretical and practical assessments while our qualified and experienced trainers are constantly on hand to provide support and guidance during the training. All Locations Aberdeen,  Glasgow,  Castleford (Wakefield), Middlesbrough,  Wellingborough,  Manchester,  Southampton,  Heathrow (London West) Exeter,  Rainham (London East)

SAY Women

say women

5.0(2)

Glasgow

SAY Women offers safe semi-supported accommodation and emotional support for young women aged 16 to 25 who are survivors of sexual abuse, rape or sexual assault and who are homeless, or threatened with homelessness. SAY Women was established in 1991 in response to CHAR research that found 4 in 10 young women who were homeless had become so due to sexual abuse. The research recognised the complex needs of young women in this position and the high risk of ongoing targeting from perpetrators due to their vulnerable circumstances. We are a charity of women supporting women who are survivors of men’s sexual violence. Using the framework of the Judith Herman model: Establishing Safety, Mourning & Remembering, Reconnection and Move On, we operate the Social Model of support. This concentrates on the experience of abuse as the issue, and recognises that the behaviours that survivors have had to use, such as self-harm and anger, are coping strategies. Collage.jpg Support for the young women is offered in the form of semi-independent living in our Accommodation Project, alongside support to prepare for a more independent lifestyle, as well as looking at the difficulties surrounding their childhood sexual abuse. They work towards moving into their own tenancy, while we offer ongoing support at our Resource Service with emotional and mental health difficulties, plus groupwork, events, activities and help with practical issues. The support we provide is flexible and varies according to what each young woman needs, so she is always in control and can access the service at a pace that suits her.